InvestorsHub Logo
Followers 26
Posts 600
Boards Moderated 0
Alias Born 12/05/2013

Re: None

Monday, 11/10/2014 12:39:31 AM

Monday, November 10, 2014 12:39:31 AM

Post# of 9935
A post on yahoo with my rebuttal:

danzimbabwe • 53 minutes ago
CTD & Trust"Intelligence" Pumpers Trying To Steal The Earle A. Chiles Research Institute's Thunder

And are trying to pass it off as PVCTs. Try again liars.
Just because their titles had similar key words in them and one was well received (EACRIs) and the other wasn't (Moffitts), doesn't mean they're both the same.

My rebuttal:

I don't think they were trying to steal anything.
They are trying to make a point.
The poster that Moffitt will publish will show that Pv-10 is the primer/stimulator being sought in those discussions.....that was the reason they attended SITC.
How effective we will all get to see soon.
It will show that the best attack against cancer is a combination of checkpoint inhibitors and immune system stimulators. Pv-10 as an tumor ablation agent is the first step...the fact that it does not damage the antigens nor the apc cells allows the immune system to finally recognize the cancer (after it has already destroyed the injected tumor in most cases). Follow that treatment with checkpoint inhibitors and you have a very powerful cancer treatment. What you end up with is a giant leap forward.

Those are the facts....no spinning.....there will be no need to pump or shake Pom poms.
The poster, once published, will say it all.

Dan, you can try to say bad things about this but it will do you no good.
The pIII trial starts, liver soon, a combo human trial will follow. Sinopharm along with all other big Pharmas were there at the SITC. The MOU will be extended. Your side has lost now....though it may take you a bit to understand that fact. Soon you will have to switch sides or move on. Being short in the stock has now become extremely dangerous. Good luck to you now. Less
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PVCT News